Evidence map›Paper›PMID 37829761›Full record

ArticleFrontiers in psychiatry2023

Severe chronic abuse of zolpidem for over 10 years: a case report and review of similar cases.

Reza Moshfeghinia, Kimia Jazi, Shabnam Kabaranzadghadim, Mahdi Malekpour, Bahare Oji

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Dependence on zopiclone: a case report.Frontiers in psychiatry · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Reza MoshfeghiniaStudent Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Kimia JaziStudent Research Committee, Faculty of Medicine, Medical University of Qom, Qom, Iran.
Shabnam KabaranzadghadimDepartment of Biochemistry, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
Mahdi MalekpourStudent Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Bahare OjiResearch Center for Psychiatry and Behavior Science, Shiraz University of Medical Sciences, Shiraz, Iran.
Shiraz University of Medical Sciences · IRQom University of Medical Science and Health Services · IRUrmia University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Insomnia is a major health issue, and zolpidem is an effective treatment for insomnia. However, high doses of zolpidem can cause dependence, abuse, and withdrawal symptoms, questioning its advantages. Case presentation: A 39-year-old woman who has been divorced and unemployed for 2 years was referred to an addiction treatment center with a chief complaint of "seizure-like withdrawal symptoms after consuming high doses of zolpidem (up to 6,000 mg per day) for a decade." These symptoms were in the form of body tremors, nystagmus, stress, anxiety, hot flashes, and sweaty palms. She has been undergoing detoxification by clonazepam for almost 2 months. Except for the first few days, she did not have any withdrawal symptoms, and her insomnia caused by zolpidem has improved. Conclusion: Chronic abuse of zolpidem can cause dependence, withdrawal symptoms, and abuse. High doses can lead to extreme cravings and dependence. Physicians must manage the withdrawal process.

Indexed as

abuseaddictiondependencehigh dosezolpidem

Identifiers

PMID37829761
PMCPMC10565798
OpenAlexW4387138262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.